Compare MEDP & CRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | CRS |
|---|---|---|
| Founded | 1992 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 15.4B |
| IPO Year | 2016 | N/A |
| Metric | MEDP | CRS |
|---|---|---|
| Price | $543.83 | $304.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $465.18 | $374.60 |
| AVG Volume (30 Days) | 277.0K | ★ 768.4K |
| Earning Date | 10-22-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 0.26% |
| EPS Growth | 25.36 | ★ 82.03 |
| EPS | ★ 14.32 | 8.18 |
| Revenue | $2,358,373,000.00 | ★ $2,893,200,000.00 |
| Revenue This Year | $21.48 | $7.26 |
| Revenue Next Year | $11.90 | $8.98 |
| P/E Ratio | $38.28 | ★ $37.56 |
| Revenue Growth | ★ 13.88 | 2.40 |
| 52 Week Low | $250.05 | $138.61 |
| 52 Week High | $626.26 | $342.11 |
| Indicator | MEDP | CRS |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 48.51 |
| Support Level | $530.96 | $306.53 |
| Resistance Level | $626.26 | $320.66 |
| Average True Range (ATR) | 18.24 | 12.49 |
| MACD | -8.14 | -3.49 |
| Stochastic Oscillator | 17.60 | 29.16 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.